Knight Therapeutics Discloses Significant Stake in Crescita Therapeutics
Knight Therapeutics Inc. formally announced on Tuesday the filing of an early warning report regarding its acquisition of shares in Crescita Therapeutics Inc. The filing, submitted to Canadian securities regulators, confirms that Knight has increased its equity position in the specialty pharmaceutical company, marking a notable shift in the ownership landscape for the Montreal-based firm….